These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 7910107

  • 1. Distinct sites of dopaminergic and glutamatergic regulation of haloperidol-induced catalepsy within the rat caudate-putamen.
    Yoshida Y, Ono T, Kawano K, Miyagishi T.
    Brain Res; 1994 Mar 07; 639(1):139-48. PubMed ID: 7910107
    [Abstract] [Full Text] [Related]

  • 2. Striatal N-methyl-D-aspartate receptors in haloperidol-induced catalepsy.
    Yoshida Y, Ono T, Kizu A, Fukushima R, Miyagishi T.
    Eur J Pharmacol; 1991 Oct 15; 203(2):173-80. PubMed ID: 1686859
    [Abstract] [Full Text] [Related]

  • 3. Dopamine increase in the prefrontal cortex correlates with reversal of haloperidol-induced catalepsy in rats.
    Tucci S, Fernandez R, Baptista T, Murzi E, Hernandez L.
    Brain Res Bull; 1994 Oct 15; 35(2):125-33. PubMed ID: 7953768
    [Abstract] [Full Text] [Related]

  • 4. Discrete quinolinic acid lesions of the lateral but not of the medial caudate-putamen reversed haloperidol-induced catalepsy in rats.
    Hauber W, Schmidt WJ.
    J Neural Transm Gen Sect; 1993 Oct 15; 94(2):103-14. PubMed ID: 8110437
    [Abstract] [Full Text] [Related]

  • 5. NMDA receptors in the rostral and intermediate-caudal striatum play an opposite role in regulation of the muscle tone in rats.
    Ossowska K, Konieczny J.
    Pol J Pharmacol; 1996 Oct 15; 48(3):261-7. PubMed ID: 9112661
    [Abstract] [Full Text] [Related]

  • 6. Striatal and nucleus accumbens D1/D2 dopamine receptors in neuroleptic catalepsy.
    Ossowska K, Karcz M, Wardas J, Wolfarth S.
    Eur J Pharmacol; 1990 Jul 03; 182(2):327-34. PubMed ID: 1975782
    [Abstract] [Full Text] [Related]

  • 7. Influence of acute and chronic haloperidol treatment on dopamine metabolism in the rat caudate-putamen, prefrontal cortex and amygdala.
    Essig EC, Kilpatrick IC.
    Psychopharmacology (Berl); 1991 Jul 03; 104(2):194-200. PubMed ID: 1876664
    [Abstract] [Full Text] [Related]

  • 8. Role of NMDA receptor subtypes in the induction of catalepsy and increase in Fos protein expression after administration of haloperidol.
    Yanahashi S, Hashimoto K, Hattori K, Yuasa S, Iyo M.
    Brain Res; 2004 Jun 11; 1011(1):84-93. PubMed ID: 15140647
    [Abstract] [Full Text] [Related]

  • 9. Prevention by (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol.
    Andersen HL, Kilpatrick IC.
    Br J Pharmacol; 1996 May 11; 118(2):421-7. PubMed ID: 8735647
    [Abstract] [Full Text] [Related]

  • 10. Glutamatergic neurotransmission mediated by NMDA receptors in the inferior colliculus can modulate haloperidol-induced catalepsy.
    Melo LL, Santos P, Medeiros P, Mello RO, Ferrari EA, Brandão ML, Maisonnette SS, Francisco A, Coimbra NC.
    Brain Res; 2010 Aug 19; 1349():41-7. PubMed ID: 20558148
    [Abstract] [Full Text] [Related]

  • 11. Delta 9-tetrahydrocannabinol-induced catalepsy-like immobilization is mediated by decreased 5-HT neurotransmission in the nucleus accumbens due to the action of glutamate-containing neurons.
    Sano K, Mishima K, Koushi E, Orito K, Egashira N, Irie K, Takasaki K, Katsurabayashi S, Iwasaki K, Uchida N, Egawa T, Kitamura Y, Nishimura R, Fujiwara M.
    Neuroscience; 2008 Jan 24; 151(2):320-8. PubMed ID: 18083311
    [Abstract] [Full Text] [Related]

  • 12. MK 801 reverses haloperidol-induced catalepsy from both striatal and extrastriatal sites in the rat brain.
    Kaur S, Ozer H, Starr M.
    Eur J Pharmacol; 1997 Aug 06; 332(2):153-60. PubMed ID: 9286616
    [Abstract] [Full Text] [Related]

  • 13. Relative importance of the dopaminergic system in haloperidol-catalepsy and the anticataleptic effect of antidepressants and methamphetamine in rats.
    Al-Khatib IM, Fujiwara M, Ueki S.
    Pharmacol Biochem Behav; 1989 May 06; 33(1):93-7. PubMed ID: 2528750
    [Abstract] [Full Text] [Related]

  • 14. Involvement of caudate nucleus, amygdala or reticular formation in neuroleptic and narcotic catalepsy.
    Dunstan R, Broekkamp CL, Lloyd KG.
    Pharmacol Biochem Behav; 1981 Feb 06; 14(2):169-74. PubMed ID: 7193882
    [Abstract] [Full Text] [Related]

  • 15. Role of mesencephalic reticular formation in cholinergic-induced catalepsy and anticholinergic reversal of neuroleptic-induced catalepsy.
    Hartgraves SL, Kelly PH.
    Brain Res; 1984 Jul 30; 307(1-2):47-54. PubMed ID: 6540616
    [Abstract] [Full Text] [Related]

  • 16. The striatal dopaminergic catalepsy mechanism is not necessary for the expression of pontine catalepsy produced by carbachol injections into the pontine reticular formation.
    Elazar Z, Peleg N, Paz M, Ring G.
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Aug 30; 352(2):187-93. PubMed ID: 7477442
    [Abstract] [Full Text] [Related]

  • 17. Glutamatergic neurotransmission in the inferior colliculus influences intrastriatal haloperidol-induced catalepsy.
    Medeiros P, Viana MB, Barbosa-Silva RC, Tonelli LC, Melo-Thomas L.
    Behav Brain Res; 2014 Jul 15; 268():8-13. PubMed ID: 24667361
    [Abstract] [Full Text] [Related]

  • 18. Catalepsy after microinjection of haloperidol into the rat medial prefrontal cortex.
    Klockgether T, Schwarz M, Turski L, Sontag KH.
    Exp Brain Res; 1988 Jul 15; 70(2):445-7. PubMed ID: 3384045
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms for metoclopramide-mediated sensitization and haloperidol-induced catalepsy in rats.
    Agovic MS, Yablonsky-Alter E, Lidsky TI, Banerjee SP.
    Eur J Pharmacol; 2008 Jun 10; 587(1-3):181-6. PubMed ID: 18457824
    [Abstract] [Full Text] [Related]

  • 20. NMDA receptor blockade attenuates the haloperidol induction of Fos protein in the dorsal but not the ventral striatum.
    de Souza IE, Meredith GE.
    Synapse; 1999 Jun 15; 32(4):243-53. PubMed ID: 10332800
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.